0001209191-12-032056.txt : 20120604
0001209191-12-032056.hdr.sgml : 20120604
20120604180244
ACCESSION NUMBER: 0001209191-12-032056
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120601
FILED AS OF DATE: 20120604
DATE AS OF CHANGE: 20120604
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: ROE ROBERT L
CENTRAL INDEX KEY: 0001286208
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50679
FILM NUMBER: 12887187
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC
CENTRAL INDEX KEY: 0001088856
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770487658
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650.688.8803
MAIL ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
4
1
doc4.xml
FORM 4 SUBMISSION
X0305
4
2012-06-01
0
0001088856
CORCEPT THERAPEUTICS INC
CORT
0001286208
ROE ROBERT L
C/O CORCEPT THERAPEUTICS
149 COMMONWEALTH DRIVE
MENLO PARK
CA
94025
0
1
0
0
President and Secretary
Common stock
2012-06-01
4
M
0
10000
1.19
A
10000
D
Common stock
2012-06-01
4
S
0
10000
4.0623
D
0
D
Stock option
1.19
2012-06-01
4
M
0
10000
0.00
D
2019-03-26
Common stock
10000
140000
D
Represents the weighted average sale price for the entire number of shares sold. The sale prices range from $4.05 to $4.07 per share. Full information on the numbers of shares sold at each sale price is available upon request.
Fully exerciseable.
s/s Joseph K. Belanoff, CEO of Corcept Therapeutics Incorporated, attorney-in-fact
2012-06-04